IBDEI10Z ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18389,0)
 ;;=711.07^^121^1166^29
 ;;^UTILITY(U,$J,358.3,18389,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18389,1,3,0)
 ;;=3^711.07
 ;;^UTILITY(U,$J,358.3,18389,1,5,0)
 ;;=5^Arthritis, Pyogenic/Septic- ankle & foot
 ;;^UTILITY(U,$J,358.3,18389,2)
 ;;=^271953
 ;;^UTILITY(U,$J,358.3,18390,0)
 ;;=716.17^^121^1166^31
 ;;^UTILITY(U,$J,358.3,18390,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18390,1,3,0)
 ;;=3^716.17
 ;;^UTILITY(U,$J,358.3,18390,1,5,0)
 ;;=5^Arthritis, Traumatic arthropathy- ankle/foot/toe
 ;;^UTILITY(U,$J,358.3,18390,2)
 ;;=^272186
 ;;^UTILITY(U,$J,358.3,18391,0)
 ;;=715.90^^121^1166^28
 ;;^UTILITY(U,$J,358.3,18391,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18391,1,3,0)
 ;;=3^715.90
 ;;^UTILITY(U,$J,358.3,18391,1,5,0)
 ;;=5^Arthritis, Osteoarthrosis- unspecified site-
 ;;^UTILITY(U,$J,358.3,18391,2)
 ;;=^272161
 ;;^UTILITY(U,$J,358.3,18392,0)
 ;;=V45.4^^121^1166^32
 ;;^UTILITY(U,$J,358.3,18392,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18392,1,3,0)
 ;;=3^V45.4
 ;;^UTILITY(U,$J,358.3,18392,1,5,0)
 ;;=5^Arthrodesis Status
 ;;^UTILITY(U,$J,358.3,18392,2)
 ;;=^97131
 ;;^UTILITY(U,$J,358.3,18393,0)
 ;;=440.20^^121^1166^24
 ;;^UTILITY(U,$J,358.3,18393,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18393,1,3,0)
 ;;=3^440.20
 ;;^UTILITY(U,$J,358.3,18393,1,5,0)
 ;;=5^Arterisclerosis obliterans- extermity
 ;;^UTILITY(U,$J,358.3,18393,2)
 ;;=^294064
 ;;^UTILITY(U,$J,358.3,18394,0)
 ;;=701.8^^121^1166^33
 ;;^UTILITY(U,$J,358.3,18394,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18394,1,3,0)
 ;;=3^701.8
 ;;^UTILITY(U,$J,358.3,18394,1,5,0)
 ;;=5^Atrophy, fat pad
 ;;^UTILITY(U,$J,358.3,18394,2)
 ;;=^88076
 ;;^UTILITY(U,$J,358.3,18395,0)
 ;;=V54.89^^121^1166^13
 ;;^UTILITY(U,$J,358.3,18395,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18395,1,3,0)
 ;;=3^V54.89
 ;;^UTILITY(U,$J,358.3,18395,1,5,0)
 ;;=5^Aftercare,Post-op, Ortho
 ;;^UTILITY(U,$J,358.3,18395,2)
 ;;=Aftercare post Surg^328685
 ;;^UTILITY(U,$J,358.3,18396,0)
 ;;=V58.49^^121^1166^14
 ;;^UTILITY(U,$J,358.3,18396,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18396,1,3,0)
 ;;=3^V58.49
 ;;^UTILITY(U,$J,358.3,18396,1,5,0)
 ;;=5^Aftercare,following Surgery
 ;;^UTILITY(U,$J,358.3,18396,2)
 ;;=^295530
 ;;^UTILITY(U,$J,358.3,18397,0)
 ;;=274.00^^121^1166^25
 ;;^UTILITY(U,$J,358.3,18397,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18397,1,3,0)
 ;;=3^274.00
 ;;^UTILITY(U,$J,358.3,18397,1,5,0)
 ;;=5^Arthritis, Gouty NOS
 ;;^UTILITY(U,$J,358.3,18397,2)
 ;;=^338313
 ;;^UTILITY(U,$J,358.3,18398,0)
 ;;=736.76^^121^1166^11
 ;;^UTILITY(U,$J,358.3,18398,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18398,1,3,0)
 ;;=3^736.76
 ;;^UTILITY(U,$J,358.3,18398,1,5,0)
 ;;=5^Adductovarus (metatarsus) acquired
 ;;^UTILITY(U,$J,358.3,18398,2)
 ;;=^272748
 ;;^UTILITY(U,$J,358.3,18399,0)
 ;;=274.01^^121^1166^26
 ;;^UTILITY(U,$J,358.3,18399,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18399,1,3,0)
 ;;=3^274.01
 ;;^UTILITY(U,$J,358.3,18399,1,5,0)
 ;;=5^Arthritis, Gouty, Acute
 ;;^UTILITY(U,$J,358.3,18399,2)
 ;;=^338226
 ;;^UTILITY(U,$J,358.3,18400,0)
 ;;=216.7^^121^1167^2
 ;;^UTILITY(U,$J,358.3,18400,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18400,1,3,0)
 ;;=3^216.7
 ;;^UTILITY(U,$J,358.3,18400,1,5,0)
 ;;=5^Benign neoplasm skin- lower limb, including hip
 ;;^UTILITY(U,$J,358.3,18400,2)
 ;;=^267636
 ;;^UTILITY(U,$J,358.3,18401,0)
 ;;=917.2^^121^1167^3
 ;;^UTILITY(U,$J,358.3,18401,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18401,1,3,0)
 ;;=3^917.2
 ;;^UTILITY(U,$J,358.3,18401,1,5,0)
 ;;=5^Blister- foot & toe(s) w/o mention of infection
 ;;^UTILITY(U,$J,358.3,18401,2)
 ;;=^275343
